Skip to Main Content

2,482

Views

1

CrossRef citations to date

0

Altmetric

Original Research

A modeling framework for the economic evaluation of baricitinib in moderate-to-severe rheumatoid arthritis

Max SchlueterReal World Solutions, IQVIA, London, UKCorrespondence[email protected]
View further author information

,

Peter RouseReal World Solutions, IQVIA, London, UK

https://orcid.org/0000-0001-8480-6607 View further author information

,

Ashley PitcherReal World Solutions, IQVIA, London, UKView further author information

,

Peita Louise Graham-ClarkeGlobal Patient Reported Outcomes and Real World Evidence (GPORWE) International, Eli Lilly, West Ryde, AustraliaView further author information

,

Claudia NicolayInternational Statistics, Lilly Deutschland GmbH, Bad Homburg, GermanyView further author information

&

Walid FakhouriGlobal Patient Reported Outcomes and Real World Evidence (GPORWE) International, Eli Lilly, Windlesham, UKView further author information